These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 33186440)

  • 1. Optimizing the synthesis of clinical trial data using sequential trees.
    Emam KE; Mosquera L; Zheng C
    J Am Med Inform Assoc; 2021 Jan; 28(1):3-13. PubMed ID: 33186440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Costs of Anonymization: Case Study Using Clinical Data.
    Pilgram L; Meurers T; Malin B; Schaeffner E; Eckardt KU; Prasser F;
    J Med Internet Res; 2024 Apr; 26():e49445. PubMed ID: 38657232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protecting patient privacy when sharing patient-level data from clinical trials.
    Tucker K; Branson J; Dilleen M; Hollis S; Loughlin P; Nixon MJ; Williams Z
    BMC Med Res Methodol; 2016 Jul; 16 Suppl 1(Suppl 1):77. PubMed ID: 27410040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current recommendations/practices for anonymising data from clinical trials in order to make it available for sharing: A scoping review.
    Rodriguez A; Tuck C; Dozier MF; Lewis SC; Eldridge S; Jackson T; Murray A; Weir CJ
    Clin Trials; 2022 Aug; 19(4):452-463. PubMed ID: 35730910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparing individual patient data from clinical trials for sharing: the GlaxoSmithKline approach.
    Hughes S; Wells K; McSorley P; Freeman A
    Pharm Stat; 2014; 13(3):179-83. PubMed ID: 24668938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility-Preserving Anonymization in a Real-World Scenario: Evidence from the German Chronic Kidney Disease (GCKD) Study.
    Pilgram L; Schäffner E; Eckardt KU; Prasser F;
    Stud Health Technol Inform; 2023 May; 302():28-32. PubMed ID: 37203603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A scalable software solution for anonymizing high-dimensional biomedical data.
    Meurers T; Bild R; Do KM; Prasser F
    Gigascience; 2021 Oct; 10(10):. PubMed ID: 34605868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Global, Neutral Platform for Sharing Trial Data.
    Bierer BE; Li R; Barnes M; Sim I
    N Engl J Med; 2016 Jun; 374(25):2411-3. PubMed ID: 27168194
    [No Abstract]   [Full Text] [Related]  

  • 9. Simulants: Synthetic Clinical Trial Data via Subject-Level Privacy-Preserving Synthesis.
    Beigi M; Shafquat A; Mezey J; Aptekar J
    AMIA Annu Symp Proc; 2022; 2022():231-240. PubMed ID: 37128411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the tradeoff between data privacy and utility with a clinical data analysis use case.
    Im E; Kim H; Lee H; Jiang X; Kim JH
    BMC Med Inform Decis Mak; 2024 May; 24(1):147. PubMed ID: 38816848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Data sharing in clinical trials - practical guidance on anonymising trial datasets.
    Keerie C; Tuck C; Milne G; Eldridge S; Wright N; Lewis SC
    Trials; 2018 Jan; 19(1):25. PubMed ID: 29321053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility-preserving anonymization for health data publishing.
    Lee H; Kim S; Kim JW; Chung YD
    BMC Med Inform Decis Mak; 2017 Jul; 17(1):104. PubMed ID: 28693480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Better Safe than Sorry - Implementing Reliable Health Data Anonymization.
    Bild R; Kuhn KA; Prasser F
    Stud Health Technol Inform; 2020 Jun; 270():68-72. PubMed ID: 32570348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anonymization Through Data Synthesis Using Generative Adversarial Networks (ADS-GAN).
    Yoon J; Drumright LN; van der Schaar M
    IEEE J Biomed Health Inform; 2020 Aug; 24(8):2378-2388. PubMed ID: 32167919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Privacy preserving data anonymization of spontaneous ADE reporting system dataset.
    Lin WY; Yang DC; Wang JT
    BMC Med Inform Decis Mak; 2016 Jul; 16 Suppl 1(Suppl 1):58. PubMed ID: 27454754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Privacy-Preserving Generative Deep Neural Networks Support Clinical Data Sharing.
    Beaulieu-Jones BK; Wu ZS; Williams C; Lee R; Bhavnani SP; Byrd JB; Greene CS
    Circ Cardiovasc Qual Outcomes; 2019 Jul; 12(7):e005122. PubMed ID: 31284738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the Utility and Privacy of Synthetic Breast Cancer Clinical Trial Data Sets.
    El Kababji S; Mitsakakis N; Fang X; Beltran-Bless AA; Pond G; Vandermeer L; Radhakrishnan D; Mosquera L; Paterson A; Shepherd L; Chen B; Barlow WE; Gralow J; Savard MF; Clemons M; El Emam K
    JCO Clin Cancer Inform; 2023 Sep; 7():e2300116. PubMed ID: 38011617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multi-institution evaluation of clinical profile anonymization.
    Heatherly R; Rasmussen LV; Peissig PL; Pacheco JA; Harris P; Denny JC; Malin BA
    J Am Med Inform Assoc; 2016 Apr; 23(e1):e131-7. PubMed ID: 26567325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of Bayesian networks to generate synthetic health data.
    Kaur D; Sobiesk M; Patil S; Liu J; Bhagat P; Gupta A; Markuzon N
    J Am Med Inform Assoc; 2021 Mar; 28(4):801-811. PubMed ID: 33367620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.